CSIMarket Company Name, Ticker, Competitors, else..
 
Carisma Therapeutics Inc   (NASDAQ: CARM)
 
Price: $0.0007 $0.00 0.000%
Day's High: $0.000699999975040555 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: -72 %
Volume (M): 1,520 52 Wk High: $ 0.39
Volume (M$): $ 0 52 Wk Avg: $0.05
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 42
 Employees 46
 Revenues (TTM) (Millions $) 53
 Net Income (TTM) (Millions $) 77
 Cash Flow (TTM) (Millions $) -24
 Capital Exp. (TTM) (Millions $) 0

Business Description


Carisma Therapeutics Inc is a biotechnology company that specializes in developing innovative cellular immunotherapies for the treatment of cancer. Their main focus is on developing chimeric antigen receptor (CAR) T-cell therapies, which involve genetically engineering a patient's own immune cells to target and destroy cancer cells. Carisma Therapeutics aims to leverage their expertise in gene editing and cell manufacturing to develop safe and effective therapies that can address the limitations of traditional cancer treatments. The company is committed to advancing the field of immunotherapy and improving patient outcomes by harnessing the power of the immune system to fight cancer.


   Company Address: 3675 Market Street Philadelphia 19104 PA
   Company Phone Number: 491-6422   Stock Exchange / Ticker: NASDAQ CARM


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BMY   -6.83%    
JNJ   -3.42%    
LLY   -3.53%    
MRK   -5.04%    
OGN   -0.91%    
PFE   -4.46%    
• View Complete Report
   



Stocks on the Move

Carisma Therapeutics Augmenting Cancer Treatment Through Immunotherapy and Strategic Leadership

Published Wed, Jul 10 2024 5:05 AM UTC

Carisma Therapeutics Appoints New Board Members, Strengthens LeadershipCarisma Therapeutics Inc. (Nasdaq: CARM) recently announced the appointment of Marella Thorell and Dr. David Scadden to its Board of Directors, effectively strengthening the company s leadership team. Their appointments come as the biopharmaceutical company aims to enhance its capabilities in the developm...
Stocks on the Move

Carisma Therapeutics Trailing Market Performance A Closer Look at Recent Developments

Published Wed, Jul 3 2024 12:54 PM UTC

Carisma Therapeutics Inc, a clinical-stage biopharmaceutical company focused on innovative immunotherapies, has experienced a period of trailing performance compared to the rest of the market. This article aims to examine recent articles and events related to Carisma Therapeutics to garner insights into the reasons behind this performance trend. Analysis:1. Carisma Therapeut...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 0.00
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.00
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.41
Working Capital Ratio 0.86
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) 200.26
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.19 $
Revenues (TTM) 1.25 $
Cash Flow (TTM) -
Cash 0.07 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,143,022
Net Income per Employee (TTM) 1,664,370
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 3.63

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) 96.83 %
Net Margin (MRQ) 197.64 %
Net Cash Flow Margin (MRQ) 1.72 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 528.22 %
Return On Investment (TTM) 1948.98 %
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Carisma Therapeutics Inc's Segments
Reporting Segment    100 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.